WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Xenon Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 10:03 am Purchase | 2023-12-29 | 13G | Xenon Pharmaceuticals Inc. XENE | WELLINGTON MANAGEMENT GROUP LLP | 4,162,654 5.560% | 4,162,654 (New Position) | Filing |